Marcin Waligora

Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting Objectives Seamless clinical trials have received much attention as a possible way to expedite drug development. The growing importance of seamless design can be seen in oncology research, especially ...

Efforts should be made to adapt the functionality of the ClinicalTrials.gov database to emerging clinical trial models. Our paper seamless trials in oncology: dx.plos.org/10.1371/jour...

...This may result in earlier access to treatment for cancer patients. One of our goals was to identify factors associated with faster results reporting. Unfortunately the current design of ClinicalTrials.gov makes reporting of seamless trials difficult.

Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting Objectives Seamless clinical trials have received much attention as a possible way to expedite drug development. The growing importance of seamless design can be seen in oncology research, especially ...

We need to adapt the functionality of the ClinicalTrials.gov database to emerging clinical trial models. In our new study we analysed seamlessly trials in oncology. Seamless trials combine two distinct phases of drug development. journals.plos.org/plosone/arti...